Maintenance Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor after First-Line Chemotherapy in Mutation-Positive Non–Small-Cell Lung Cancer

No abstract available
Source: Journal of Thoracic Oncology - Category: Cancer & Oncology Tags: Letters to the Editor Source Type: research